Immunosenescence (iSenescence) correlates with disease progression in advanced non-small cell lung cancer (aNSCLC) patients treated with PD-(L)1 inhibitors (IO)

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 29; p. viii511
Main Authors Ferrara, R., Naigeon, M., Auclin, E., Duchemann, B., Cassard, L., Medhi, J., Boselli, L., Grivel, J., Desnoyer, A., Mezquita, L., Aboubakar, F., Hendriks, L., Planchard, D., Caramella, C., Remon, J., Ngocamus, M., Nicotra, C., Besse, B., Chaput, N.
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.10.2018
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdy292.038